Eqis Capital Management, Inc. United Therapeutics Corp Transaction History
Eqis Capital Management, Inc.
- $1.17 Billion
- Q2 2024
A detailed history of Eqis Capital Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 813 shares of UTHR stock, worth $289,216. This represents 0.02% of its overall portfolio holdings.
Number of Shares
813
Previous 1,084
25.0%
Holding current value
$289,216
Previous $249,000
3.61%
% of portfolio
0.02%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding UTHR
# of Institutions
618Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.95 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.57 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.17 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$816 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...